The Benefits of Using Yervoy (a CTLA-4 Inhibitor) for Intratumoral Immunotherapy
Immunotherapy has revolutionized cancer treatment by harnessing the power of the immune system to fight cancer. Yervoy (Ipilimumab), a CTLA-4 inhibitor, is a type of immunotherapy that has shown great promise in treating various types of cancer. When used in intratumoral immunotherapy, Yervoy has several benefits that can enhance its effectiveness.
The post The Benefits of Using Yervoy (a CTLA-4 Inhibitor) for Intratumoral Immunotherapy appeared first on Williams Cancer Institute. Via https://williamscancerinstitute.com/the-benefits-of-using-yervoy-a-ctla-4-inhibitor-for-intratumoral-immunotherapy/
0 Comments
Leave a Reply. |